89 related articles for article (PubMed ID: 10091728)
41. [Identification of new substrates of cyclin-activated kinases in breast cancers].
Lilischkis R; Barczak E; Marwedel M; Mehraein Y; Lauterlein M; Lüscher B; Kreipe H
Verh Dtsch Ges Pathol; 2001; 85():269-74. PubMed ID: 11894409
[TBL] [Abstract][Full Text] [Related]
42. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer.
Yamamoto H; Monden T; Ikeda K; Izawa H; Fukuda K; Fukunaga M; Tomita N; Shimano T; Shiozaki H; Monden M
Br J Cancer; 1995 Jun; 71(6):1231-6. PubMed ID: 7779716
[TBL] [Abstract][Full Text] [Related]
43. Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
Hsieh HF; Harn HJ; Chiu SC; Liu YC; Lui WY; Ho LI
Liver; 2000 Apr; 20(2):143-51. PubMed ID: 10847483
[TBL] [Abstract][Full Text] [Related]
44. p107 Expression in colorectal tumours rises during carcinogenesis and falls during invasion.
Wu F; Li JQ; Miki H; Nishioka M; Fujita J; Ohmori M; Imaida K; Kuriyama S
Eur J Cancer; 2002 Sep; 38(14):1838-48. PubMed ID: 12204665
[TBL] [Abstract][Full Text] [Related]
45. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas.
Kitahara K; Yasui W; Kuniyasu H; Yokozaki H; Akama Y; Yunotani S; Hisatsugu T; Tahara E
Int J Cancer; 1995 Jul; 62(1):25-8. PubMed ID: 7601562
[TBL] [Abstract][Full Text] [Related]
46. Tyrosine phosphorylation in mouse mammary hyperplasias.
Said TK; Medina D
Carcinogenesis; 1995 Apr; 16(4):923-30. PubMed ID: 7728975
[TBL] [Abstract][Full Text] [Related]
47. Correlation between the expressions of gastrin, somatostatin and cyclin and cyclin-depend kinase in colorectal cancer.
Wu P; Mao JD; Yan JY; Rui J; Zhao YC; Li XH; Xu GQ
World J Gastroenterol; 2005 Dec; 11(45):7211-7. PubMed ID: 16437675
[TBL] [Abstract][Full Text] [Related]
48. Cell cycle regulators during human atrial development.
Kim WH; Joo CU; Ku JH; Ryu CH; Koh KN; Koh GY; Ko JK
Korean J Intern Med; 1998 Jul; 13(2):77-82. PubMed ID: 9735660
[TBL] [Abstract][Full Text] [Related]
49. Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
Marone M; Scambia G; Giannitelli C; Ferrandina G; Masciullo V; Bellacosa A; Benedetti-Panici P; Mancuso S
Int J Cancer; 1998 Jan; 75(1):34-9. PubMed ID: 9426687
[TBL] [Abstract][Full Text] [Related]
50. Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells.
Seabra L; Warenius H
Eur J Cancer; 2007 Jun; 43(9):1483-92. PubMed ID: 17481885
[TBL] [Abstract][Full Text] [Related]
51. Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus.
Zhai YL; Nikaido T; Shiozawa T; Orii A; Fujii S
Int J Cancer; 1999 Jun; 84(3):244-50. PubMed ID: 10371341
[TBL] [Abstract][Full Text] [Related]
52. A sporadic, atypical case of desminopathy: morphological and immunological characterization.
Prelle A; Sciacco M; Comi GP; Messina S; Carpo M; Ciscato P; Nobile Orazio E; Fortunato F; Mora G; Bignotti V; Fagiolari G; Moggio M; Scarlato G
Clin Neuropathol; 2000; 19(4):208-12. PubMed ID: 10919353
[TBL] [Abstract][Full Text] [Related]
53. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections.
Ikeda K; Monden T; Kanoh T; Tsujie M; Izawa H; Haba A; Ohnishi T; Sekimoto M; Tomita N; Shiozaki H; Monden M
J Histochem Cytochem; 1998 Mar; 46(3):397-403. PubMed ID: 9487122
[TBL] [Abstract][Full Text] [Related]
54. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers.
Kolonin MG; Finley RL
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14266-71. PubMed ID: 9826689
[TBL] [Abstract][Full Text] [Related]
55. Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis.
An X; Ng SS; Xie D; Zeng YX; Sze J; Wang J; Chen YC; Chow BK; Lu G; Poon WS; Kung HF; Wong BC; Lin MC
Eur J Cancer; 2010 Jun; 46(9):1752-61. PubMed ID: 20466538
[TBL] [Abstract][Full Text] [Related]
56. Promising Anticancer Activity of Multitarget Cyclin Dependent Kinase Inhibitors against Human Colorectal Carcinoma Cells.
Manohar SM; Joshi KS
Curr Mol Pharmacol; 2022; 15(7):1024-1033. PubMed ID: 35068399
[TBL] [Abstract][Full Text] [Related]
57. Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer.
Li N; Zheng S; Xue Z; Xiong Z; Zou Y; Tang Y; Wei WD; Yang L
Aging (Albany NY); 2021 Mar; 13(6):8095-8114. PubMed ID: 33686962
[TBL] [Abstract][Full Text] [Related]
58. Different expression patterns of cyclins A, D1 and E in human colorectal cancer.
Wang A; Yoshimi N; Suzui M; Yamauchi A; Tarao M; Mori H
J Cancer Res Clin Oncol; 1996; 122(2):122-6. PubMed ID: 8576279
[TBL] [Abstract][Full Text] [Related]
59. Aspirin metabolites 2,3‑DHBA and 2,5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention.
Sankaranarayanan R; Valiveti CK; Dachineni R; Kumar DR; Lick T; Bhat GJ
Mol Med Rep; 2020 Jan; 21(1):20-34. PubMed ID: 31746356
[TBL] [Abstract][Full Text] [Related]
60. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.
Sun GG; Zhang J; Hu WN
Tumour Biol; 2014 Apr; 35(4):3339-46. PubMed ID: 24307622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]